Can-Fite BioPharma (CANF) Announces Phase III ACRobat Trial in RA Approved by Institutional Review Board
Tweet Send to a Friend
Barzilai Medical Center in Israel ready to enroll patientsIRB approvals in European and Canadian medical centers expected to follow ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
